Smith Hunter C sold RYTM
July 9, 2025 · Form 4 insider transaction
Smith Hunter C sold 23,400 shares of Rhythm Pharmaceuticals, Inc. at $84.50 per share, a transaction worth $1.98M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
23,400
Price
$84.50
Total value
$1.98M
InsiderSmith Hunter C
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 9, 2025
Filing dateJuly 11, 2025
Shares owned after116,915
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025.